| 121 |
Evaluation of autophagy-related genes in Egyptian systemic
lupus erythematosus patients
|
2020 |
| 122 |
Evaluation of autophagy-related genes in Egyptian systemic
lupus erythematosus patients
|
2020 |
| 123 |
Evaluation of autophagy-related genes in Egyptian systemic
lupus erythematosus patients
|
2020 |
| 124 |
Evaluation of autophagy-related genes in Egyptian systemic
lupus erythematosus patients
|
2020 |
| 125 |
Evaluation of the neuroprotective effect of donepezil in type 2 diabetic rats |
2020 |
| 126 |
Factors Associated with Increased Morbidity and Mortality of Obese and Overweight COVID-19 Patients |
2020 |
| 127 |
Impact of comorbidities on COVID-19 outcome |
2020 |
| 128 |
Impact of deranged B cell subsets distribution in the development of HCV‑related cirrhosis and HCC
in type two diabetes mellitus |
2020 |
| 129 |
Impact of deranged B cell subsets distribution in the development of HCV‑related cirrhosis and HCC
in type two diabetes mellitus |
2020 |
| 130 |
Impact of deranged B cell subsets distribution in the development of HCV‑related cirrhosis and HCC
in type two diabetes mellitus |
2020 |